how many people in the us take glp 1 Big shift U.S. health! A new Gallup poll shows 11% of Americans now taking GLP-1 drugs, coinciding with obesity rates dropping to 36.4% (down from 39.9% in 2022). Promising progress in 1 in 8 adults in

The additive effect of these symptoms could significantly impact daily functioning and quality of life

Serious side effects requiring medical attention Tirzepatide carries a boxed warning about thyroid C-cell tumors

(Zingiberaceae) in experimental mice and its possible mechanism of action

Though not a peptide in the classical sense, NAD+ has become a core subject in peptide therapy research because its functional decline with biological age intersects directly with peptide-regulated longevity pathways and cellular health outcomes

Curcumin, psyllium, cinnamon, and ginseng each have human RCT evidence supporting their metabolic effects